ANXA10

Across TCGA pan-cancer cohorts, ANXA10 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ANXA10 data layer compared with 21 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ANXA10 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANXA10 expression acts as an unfavorable survival marker.

LUAD are the cancer types where ANXA10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.237	0.709	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ANXA10–LUAD (OS)

Open the LUAD breakdown →